These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9354236)

  • 1. Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analogues.
    Madalengoitia JS; Tepe JJ; Werbovetz KA; Lehnert EK; Macdonald TL
    Bioorg Med Chem; 1997 Sep; 5(9):1807-15. PubMed ID: 9354236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei.
    Vilarem MJ; Riou JF; Multon E; Gras MP; Larsen CJ
    Biochem Pharmacol; 1986 Jul; 35(13):2087-95. PubMed ID: 3015146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
    Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
    J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.
    Leteurtre F; Madalengoitia J; Orr A; Guzi TJ; Lehnert E; Macdonald T; Pommier Y
    Cancer Res; 1992 Aug; 52(16):4478-83. PubMed ID: 1322792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
    Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
    Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.
    Eymin B; Solary E; Chevillard S; Dubrez L; Goldwasser F; Duchamp O; Genne P; Leteurtre F; Pommier Y
    Int J Cancer; 1995 Oct; 63(2):268-75. PubMed ID: 7591216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.
    Fossé P; René B; Charra M; Paoletti C; Saucier JM
    Mol Pharmacol; 1992 Oct; 42(4):590-5. PubMed ID: 1331751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.
    Monnot M; Mauffret O; Simon V; Lescot E; Psaume B; Saucier JM; Charra M; Belehradek J; Fermandjian S
    J Biol Chem; 1991 Jan; 266(3):1820-9. PubMed ID: 1846365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions of DNA-topoisomerase I and II inhibitor with DNA and topoisomerases and in ternary complexes: binding modes and biological effects for intoplicine derivatives.
    Nabiev I; Chourpa I; Riou JF; Nguyen CH; Lavelle F; Manfait M
    Biochemistry; 1994 Aug; 33(30):9013-23. PubMed ID: 8043587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II.
    Fossé P; René B; Saucier JM; Nguyen CH; Bisagni E; Paoletti C
    Biochem Pharmacol; 1990 Feb; 39(4):669-76. PubMed ID: 2154990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II.
    Li Y; Luan Y; Qi X; Li M; Gong L; Xue X; Wu X; Wu Y; Chen M; Xing G; Yao J; Ren J
    Toxicol Sci; 2010 Dec; 118(2):435-43. PubMed ID: 20855424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.
    Kao YH; Hsieh HP; Chitlimalla SK; Pan WY; Kuo CC; Tsai YC; Lin WH; Chuang SE; Chang JY
    Anticancer Drugs; 2008 Feb; 19(2):151-8. PubMed ID: 18176111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
    Riou JF; Grondard L; Naudin A; Bailly C
    Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.
    Solary E; Leteurtre F; Paull KD; Scudiero D; Hamel E; Pommier Y
    Biochem Pharmacol; 1993 Jun; 45(12):2449-56. PubMed ID: 8392342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.
    Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.
    Chang SM; Christian W; Wu MH; Chen TL; Lin YW; Suen CS; Pidugu HB; Detroja D; Shah A; Hwang MJ; Su TL; Lee TC
    Eur J Med Chem; 2017 Feb; 127():235-249. PubMed ID: 28064078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.